Image_2_c-Rel Is Required for IL-33-Dependent Activation of ILC2s.tif
Group 2 innate lymphoid cells (ILC2s) are emerging as important cellular regulators of homeostatic and disease-associated immune processes. The cytokine interleukin-33 (IL-33) promotes ILC2-dependent inflammation and immunity, with IL-33 having been shown to activate NF-κB in a wide variety of cell types. However, it is currently unclear which NF-κB members play an important role in IL-33-dependent ILC2 biology. Here, we identify the NF-κB family member c-Rel as a critical component of the IL-33-dependent activation of ILC2s. Although c-Rel is dispensable for ILC2 development, it is critical for ILC2 function in the lung, with c-Rel-deficient (c-Rel–/–) mice present a significantly reduced response to papain- and IL-33-induced lung inflammation. We also show that the absence of c-Rel reduces the IL-33-dependent expansion of ILC2 precursors and lower levels of IL-5 and IL-13 cytokine production by mature ILC2s in the lung. Together, these results identify the IL-33-c-Rel axis as a central control point of ILC2 activation and function.
History
References
- https://doi.org//10.1038/ni.3489
- https://doi.org//10.1038/nri.2016.95
- https://doi.org//10.1084/jem.20170449
- https://doi.org//10.1038/ni.3078
- https://doi.org//10.1002/eji.201142018
- https://doi.org//10.1084/jem.20130351
- https://doi.org//10.1016/j.immuni.2014.01.011
- https://doi.org//10.1038/sj.onc.1209954
- https://doi.org//10.1038/ni.2065
- https://doi.org//10.1016/j.gene.2016.01.025
- https://doi.org//10.3389/fimmu.2017.00475
- https://doi.org//10.1093/intimm/dxn037
- https://doi.org//10.1038/83158
- https://doi.org//10.1038/nature13577
- https://doi.org//10.1182/blood-2015-12-684142
- https://doi.org//10.1038/ni.2920
- https://doi.org//10.4049/jimmunol.181.1.62
- https://doi.org//10.1016/j.jaci.2009.02.026
- https://doi.org//10.4049/jimmunol.0901575
- https://doi.org//10.1038/nature08900
- https://doi.org//10.1073/pnas.1003988107
- https://doi.org//10.1038/s41467-020-18601-7
- https://doi.org//10.1016/j.celrep.2019.11.102
- https://doi.org//10.1084/jem.20191054
- https://doi.org//10.1101/gad.9.16.1965
- https://doi.org//10.1093/nar/17.15.6419
- https://doi.org//10.1128/IAI.01240-15
- https://doi.org//10.1038/376167a0
- https://doi.org//10.1016/j.immuni.2012.06.012
- https://doi.org//10.1016/j.immuni.2012.06.020
- https://doi.org//10.1084/jem.20151646
- https://doi.org//10.1073/pnas.1217158110
- https://doi.org//10.1073/pnas.1003059107
- https://doi.org//10.1016/j.immuni.2011.12.020
- https://doi.org//10.1016/S1074-7613%2800%2980423-9
- https://doi.org//10.1016/j.cell.2017.08.004
- https://doi.org//10.1371/journal.ppat.1003615
- https://doi.org//10.1038/ni.2743
- https://doi.org//10.1084/jem.20150851
- https://doi.org//10.1016/j.immuni.2012.12.003
- https://doi.org//10.4049/jimmunol.1301228
- https://doi.org//10.1016/j.celrep.2019.11.102
- https://doi.org//10.1038/ni.3447
- https://doi.org//10.1016/j.str.2009.08.009
- https://doi.org//10.1073/pnas.1308651110
- https://doi.org//10.1016/j.immuni.2015.02.011
- https://doi.org//10.1016/j.immuni.2009.05.007
- https://doi.org//10.4049/jimmunol.180.4.2443
- https://doi.org//10.1371/journal.pone.0003331
- https://doi.org//10.4049/jimmunol.1101977
- https://doi.org//10.4049/jimmunol.170.7.3724
- https://doi.org//10.4049/jimmunol.175.6.3790
- https://doi.org//10.1016/j.immuni.2009.10.006
- https://doi.org//10.1016/j.jaci.2014.06.024
- https://doi.org//10.1016/j.jaci.2014.07.029
- https://doi.org//10.1183/13993003.01809-2018
- https://doi.org//10.1016/j.jaci.2013.05.012
- https://doi.org//10.4049/jimmunol.1102832
- https://doi.org//10.1016/j.jaci.2017.12.1006
- https://doi.org//10.1056/NEJMoa0906312
- https://doi.org//10.4049/jimmunol.0802387
- https://doi.org//10.1016/j.jaci.2013.12.610
- https://doi.org//10.1177/1947601911421925
- https://doi.org//10.4049/jimmunol.178.11.7097
- https://doi.org//10.1084/jem.20021610
- https://doi.org//10.1101/cshperspect.a000182
- https://doi.org//10.4049/jimmunol.1800539
- https://doi.org//10.1111/cea.12491
- https://doi.org//10.1038/nature05590
- https://doi.org//10.1158/0008-5472.CAN-14-2814
- https://doi.org//10.1158/2159-8290.cd-13-0585
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity